Jurickson Profar, designated hitter for the Atlanta Braves, has been suspended for 162 games after testing positive for a performance-enhancing drug, sources informed ESPN’s Jeff Passan. This penalty bars Profar from participating in the entire upcoming season, including the postseason and the World Baseball Classic, where he was expected to represent the Netherlands, while forfeiting his $15 million salary.
Details of Profar’s Previous Suspension and Substance Involved
Profar was previously suspended for 80 games last year due to testing positive for Chorionic Gonadotrophin (hCG), a hormone linked to testosterone production according to the Cleveland Clinic. This earlier suspension also came under the Major League Baseball’s drug prevention and treatment program rules. At that time, Profar expressed deep regret, calling the incident
“the most difficult day of my baseball career.”
He further stated,
“This is especially painful for me because anyone who knows me and has seen me play knows I am deeply passionate about the game,”
expressing his commitment to fair competition and offering an apology to the Braves organization, teammates, and fans.
Context of the Suspension Amid MLB’s Strict Drug Policies
Jeff Passan reports that Profar is now the sixth player to receive this level of suspension since Major League Baseball implemented harsher penalties for repeat offenders more than ten years ago. The league’s increased crackdown aims to maintain fair play and integrity within professional baseball.
Profar had signed a lucrative three-year, $42 million contract with the Braves last year following his tenure with the San Diego Padres. This suspension marks a significant setback for both the player and the team.
Implications for Profar and the Braves Moving Forward
The full-season suspension not only affects Profar’s career and earnings but also impacts the Braves’ lineup and postseason prospects. His absence during the upcoming season leaves a gap in their designated hitter spot and reduces their depth for critical games. The situation underscores ongoing challenges MLB faces with PED-related violations and the importance of compliance with league policies.
